Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.

Int J Nanomedicine · 2020 · PMC7756023 · PMID 33376321

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It was found that the Her2-targeted nanoparticles showed a trend of gradual enrichment and then regression in the tumor site, and the content of nanoparticles was the highest in tumor after 2 h of intravenous injection ( Figure 9A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.